MedPath

Study of vitamin K2-7 (MK-7) in patients with tingling and numbness due to diabetes and/or vitamin B12 deficiency

Phase 4
Completed
Conditions
Health Condition 1: null- Neuropathy occurring because of vitamin B12 deficiency and type 2 Diabetes Melitus
Registration Number
CTRI/2017/06/008925
Lead Sponsor
Synergia Life Sciences Pvt Ltd
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
60
Inclusion Criteria

1.Male and female aged 18 to 65 who are suffering from type 2 diabetes mellitus and/ or vitamin B12 deficiency.

2.Symptomatic diagnosis of neuropathy ( >4 on VAS score).

3.Willing to give informed consent.

Exclusion Criteria

1.Patients who are suffering from any other systemic illness other than type 2 diabetes mellitus or vitamin B12 deficiency.

2.Patients who are on corticosteroids and oral contraceptives.

3.Patients with seropositive status.

4.Pregnancy.

5.Patients Participation in clinical trials evaluating investigational pharmaceuticals or biologics within 3 months or devices within 30 days of admission to the study.

6.Patients who are on coumarin analogues.

7.Patients who are on Quinine Hydrochloride.

8.History of alcohol. substance abuse or alcoholism, within the previous one year.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath